This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This FBXL13 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 683-710 amino acids from the C-terminal region of human FBXL13.
FBXL13
Reaktivität: Human
WB, ELISA
Wirt: Kaninchen
Polyclonal
APC
Applikationshinweise
For WB starting dilution is: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.45 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
FBXL13
(F-Box and Leucine-Rich Repeat Protein 13 (FBXL13))
FBXL13 antikoerper, Fbxl13 antikoerper, MGC95282 antikoerper, Fbl13 antikoerper, 4921539K22Rik antikoerper, F24J1.28 antikoerper, F-box and leucine rich repeat protein 13 antikoerper, F-box and leucine-rich repeat protein 13 antikoerper, F-box/RNI-like superfamily protein antikoerper, FBXL13 antikoerper, Fbxl13 antikoerper, AT1G69630 antikoerper
Hintergrund
Members of the F-box protein family, such as FBXL13, are characterized by an approximately 40-amino acid F-box motif. SCF complexes, formed by SKP1 (MIM 601434), cullin (see CUL1, MIM 603134), and F-box proteins, act as protein-ubiquitin ligases. F-box proteins interact with SKP1 through the F box, and they interact with ubiquitination targets through other protein interaction domains (Jin et al., 2004 [PubMed 15520277]).[supplied by OMIM].